MMG names Chris Middleton vice president of technology

Friday, February 10, 2012 11:47 AM

MMG, a global clinical trials patient recruitment group, part of Ketchum, has appointed Chris Middleton vice president of technology.

Middleton will oversee all new technology products and application, service and infrastructure development. He will provide leadership and strategic direction for MMG's portfolio of technology-based patient recruitment efforts.

Middleton is a software industry veteran with a track record in complex software development across the healthcare, privacy, biometrics and enterprise integration industries, both in the U.S. and internationally. In addition to being a software architect and technology manager for companies such as CGI-AMS, Software AG, Deutsche Post DHL and Daon, Middleton has held leadership positions for software startups and founded Scaled Objects in 2007.

"Chris' passion for developing novel technology solutions that bridge gaps between patients and the services they need is perfectly suited for achieving MMG's aggressive goals for innovating and meeting our clients' needs,” said John Benbrook, CEO of MMG.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs